EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • February 25th, 2016 • Synergy Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 25th, 2016 Company Industry JurisdictionThis EXECUTIVE EMPLOYMENT AGREEMENT (the “Agreement”) dated as of May 29, 2015 is made and entered into by and between Synergy Pharmaceuticals Inc., a company incorporated under the laws of the state of Delaware (the “Company”), and Troy M. Hamilton, an individual (the “Executive”).
ContractExecutive Employment Agreement • February 25th, 2016 • Synergy Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 25th, 2016 Company Industry JurisdictionThis AMENDMENT (the “Amendment”) to the FOURTH AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (the “Agreement”) originally dated as of January 7, 2015, by and between Synergy Pharmaceuticals Inc., a Delaware corporation (the “Company”) and Gary S. Jacob, Ph.D. (the “Executive”) is dated as of January 18, 2016. Capitalized terms not defined herein shall have the meanings assigned to them in the Agreement.
ContractExecutive Employment Agreement • February 25th, 2016 • Synergy Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 25th, 2016 Company Industry JurisdictionThis AMENDMENT (the “Amendment”) to the EXECUTIVE EMPLOYMENT AGREEMENT (the “Agreement”) originally dated as of May 29, 2015, by and between Synergy Pharmaceuticals Inc., a Delaware corporation (the “Company”) and Troy M. Hamilton (the “Executive”) is dated as of January 18, 2016. Capitalized terms not defined herein shall have the meanings assigned to them in the Agreement.
ContractExecutive Employment Agreement • February 25th, 2016 • Synergy Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 25th, 2016 Company Industry JurisdictionThis AMENDMENT (the “Amendment”) to the AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (the “Agreement”) originally dated as of July 12, 2013, by and between Synergy Pharmaceuticals Inc., a Delaware corporation (the “Company”) and Patrick H. Griffin, M.D., FACP (the “Executive”) is dated as of January 18, 2016. Capitalized terms not defined herein shall have the meanings assigned to them in the Agreement.
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • February 25th, 2016 • Synergy Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 25th, 2016 Company Industry JurisdictionThis EXECUTIVE EMPLOYMENT AGREEMENT (the “Agreement”) dated as of November 10, 2015 is made and entered into by and between Synergy Pharmaceuticals Inc., a company incorporated under the laws of the state of Delaware (the “Company”), and Gary L. Sender, M.S., an individual (the “Executive”).
AMENDMENT TO THIRD AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • February 25th, 2016 • Synergy Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 25th, 2016 Company Industry JurisdictionThis AMENDMENT (the “Amendment”) to the THIRD AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (the “Agreement”) originally dated as of January 7, 2015, by and between Synergy Pharmaceuticals Inc., a Delaware corporation (the “Company”) and Kunwar Shailubhai (the “Executive”) is dated as of January 18, 2016. Capitalized terms not defined herein shall have the meanings assigned to them in the Agreement.